Marshall Wace’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.27M Sell
269,587
-1,106,152
-80% -$32.9M 0.01% 1279
2025
Q4
$42.8M Buy
1,375,739
+506,551
+58% +$13.9M 0.04% 385
2025
Q3
$18.8M Sell
869,188
-338,683
-28% -$6.11M 0.02% 679
2025
Q2
$16.9M Buy
1,207,871
+123,831
+11% +$1.68M 0.02% 649
2025
Q1
$14.6M Buy
+1,084,040
New +$18.5M 0.02% 623
2024
Q4
Sell
-684,799
Closed -$15.6M 3070
2024
Q3
$15.6M Buy
684,799
+611,825
+838% +$10M 0.02% 593
2024
Q2
$949K Sell
72,974
-5,727
-7% -$79.3K ﹤0.01% 1715
2024
Q1
$1.38M Sell
78,701
-222,588
-74% -$4.32M ﹤0.01% 1524
2023
Q4
$6.56M Sell
301,289
-661,204
-69% -$10.4M 0.01% 818
2023
Q3
$14.8M Buy
962,493
+311,314
+48% +$5.94M 0.03% 519
2023
Q2
$15.5M Buy
651,179
+21,859
+3% +$561K 0.03% 574
2023
Q1
$16M Buy
629,320
+17,863
+3% +$573K 0.04% 540
2022
Q4
$17.9M Buy
611,457
+2,795
+0.5% +$64.4K 0.05% 496
2022
Q3
$12.5M Buy
608,662
+163,863
+37% +$2.95M 0.03% 721
2022
Q2
$5.14M Buy
444,799
+427,236
+2,433% +$5.74M 0.01% 1316
2022
Q1
$326K Sell
17,563
-70,842
-80% -$1.36M ﹤0.01% 2943
2021
Q4
$1.75M Buy
+88,405
New +$1.65M ﹤0.01% 2123

Other funds holding VRDN